FULCRUM THERAPEUTICS INC
FULCNASDAQ🏆 #3325 by market capEarnings Feb 22 · PostUS Equity
$3.77▲ $0.02 (+0.53%)
Market closed · at closeTrack FULC
Get earnings, price moves & breaking news on Telegram
24h▲ 0.5%
7d▲ 2.3%
14d▲ 3.0%
30d▲ 2.2%
ytd▼ 66.7%
1y▼ 56.1%
🏦Market Cap
$288M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
3.5x
Fair
Otter Score
—
Insufficient data
FULCRUM THERAPEUTICS INC
FULCAnalyst Ratings
Price
$3.77
Total
17
Raised
1
Lowered
7
Avg PT
$3.60
H / L
$4 / $3
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
JP Morgan | Downgraded | Overweight → Underweight | 2026-06-03 | — | — |
Truist Securities | Downgraded | Buy → Hold | 2026-06-02 | — | — |
Leerink Partners | Downgraded | Outperform → Market Perform | 2026-06-02 | $4.00 | +6.10% |
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2026-06-02 | — | — |
Stifel | Downgraded | Buy → Hold | 2026-06-02 | — | — |
Piper Sandler | Downgraded | Overweight → Underweight | 2026-06-02 | $3.00 | −20.40% |
B of A Securities | Reiterated | Underperform | 2025-12-09 | — | — |
RBC Capital | Reiterated | Sector Perform | 2025-12-08 | $10.00 | +165.30% |
Cantor Fitzgerald | Reiterated | Overweight | 2025-12-08 | $24.00 | +536.60% |
Oppenheimer | Reiterated | Outperform | 2024-05-14 | — | — |
Goldman Sachs | Upgraded | Neutral → Buy | 2024-05-14 | $15.00 | +297.90% |
Credit Suisse | Downgraded | Outperform → Neutral | 2023-03-10 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2023-03-10 | — | — |
SVB Leerink | Reiterated | Outperform | 2021-08-13 | — | — |
BTIG | Reiterated | Buy | 2020-06-17 | — | — |
H.C. Wainwright | Reiterated | Buy | 2020-03-06 | $3.00 | −20.40% |
Bank of America | Reiterated | Buy | 2019-08-12 | — | — |
Institution
JP Morgan
Downgraded · Overweight → Underweight · 2026-06-03
—
—
Truist Securities
Downgraded · Buy → Hold · 2026-06-02
—
—
Leerink Partners
Downgraded · Outperform → Market Perform · 2026-06-02
$4.00
+6.10%
HC Wainwright & Co.
Downgraded · Buy → Neutral · 2026-06-02
—
—
Stifel
Downgraded · Buy → Hold · 2026-06-02
—
—
Piper Sandler
Downgraded · Overweight → Underweight · 2026-06-02
$3.00
−20.40%
B of A Securities
Reiterated · Underperform · 2025-12-09
—
—
RBC Capital
Reiterated · Sector Perform · 2025-12-08
$10.00
+165.30%
Cantor Fitzgerald
Reiterated · Overweight · 2025-12-08
$24.00
+536.60%
Oppenheimer
Reiterated · Outperform · 2024-05-14
—
—
Goldman Sachs
Upgraded · Neutral → Buy · 2024-05-14
$15.00
+297.90%
Credit Suisse
Downgraded · Outperform → Neutral · 2023-03-10
—
—
Morgan Stanley
Reiterated · Equal Weight · 2023-03-10
—
—
SVB Leerink
Reiterated · Outperform · 2021-08-13
—
—
BTIG
Reiterated · Buy · 2020-06-17
—
—
H.C. Wainwright
Reiterated · Buy · 2020-03-06
$3.00
−20.40%
Bank of America
Reiterated · Buy · 2019-08-12
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space